Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Atp6v1f | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | multiple interactions | ISO | Atp6v1f (Mus musculus) | 6480464 | [Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of more ... | CTD | PMID:38995820 | Atp6v1f | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Atp6v1f (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATP6V1F mRNA | CTD | PMID:24680724 | Atp6v1f | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP6V1F mRNA | CTD | PMID:33387578 | Atp6v1f | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATP6V1F mRNA | CTD | PMID:34747641 | Atp6v1f | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of ATP6V1F mRNA | CTD | PMID:30851411 | Atp6v1f | Rat | 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of ATP6V1F mRNA | CTD | PMID:19483382 | Atp6v1f | Rat | 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of ATP6V1F mRNA | CTD | PMID:19483382 | Atp6v1f | Rat | aconitine | increases expression | EXP | | 6480464 | Aconitine results in increased expression of ATP6V1F protein | CTD | PMID:33236894 | Atp6v1f | Rat | aflatoxin B1 | increases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of ATP6V1F mRNA | CTD | PMID:27153756 | Atp6v1f | Rat | amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of ATP6V1F mRNA | CTD | PMID:19483382 | Atp6v1f | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ATP6V1F mRNA | CTD | PMID:16483693 | Atp6v1f | Rat | aristolochic acid A | increases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of ATP6V1F mRNA | CTD | PMID:33212167 | Atp6v1f | Rat | arsenite(3-) | multiple interactions | ISO | ATP6V1F (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to ATP6V1F mRNA] | CTD | PMID:32406909 | Atp6v1f | Rat | benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of ATP6V1F mRNA | CTD | PMID:19483382 | Atp6v1f | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Atp6v1f (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of ATP6V1F mRNA | CTD | PMID:33754040 | Atp6v1f | Rat | bisphenol A | decreases expression | ISO | Atp6v1f (Mus musculus) | 6480464 | bisphenol A results in decreased expression of ATP6V1F mRNA | CTD | PMID:26512966|PMID:35598803 | Atp6v1f | Rat | bisphenol A | multiple interactions | ISO | ATP6V1F (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATP6V1F gene | CTD | PMID:31601247 | Atp6v1f | Rat | bisphenol A | increases expression | ISO | Atp6v1f (Mus musculus) | 6480464 | bisphenol A results in increased expression of ATP6V1F mRNA | CTD | PMID:33221593 | Atp6v1f | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ATP6V1F mRNA | CTD | PMID:25181051 | Atp6v1f | Rat | cadmium dichloride | increases expression | ISO | Atp6v1f (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of ATP6V1F mRNA | CTD | PMID:30030080 | Atp6v1f | Rat | cadmium dichloride | increases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of ATP6V1F mRNA | CTD | PMID:38568856 | Atp6v1f | Rat | CGP 52608 | multiple interactions | ISO | ATP6V1F (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ATP6V1F gene] | CTD | PMID:28238834 | Atp6v1f | Rat | chloropicrin | increases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | chloropicrin results in increased expression of ATP6V1F mRNA | CTD | PMID:26352163 | Atp6v1f | Rat | chlorpyrifos | increases expression | ISO | Atp6v1f (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ATP6V1F mRNA | CTD | PMID:37019170 | Atp6v1f | Rat | clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of ATP6V1F mRNA | CTD | PMID:19483382 | Atp6v1f | Rat | cyclosporin A | increases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ATP6V1F mRNA | CTD | PMID:25562108 | Atp6v1f | Rat | cyclosporin A | decreases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ATP6V1F mRNA | CTD | PMID:27989131 | Atp6v1f | Rat | cypermethrin | increases expression | EXP | | 6480464 | cypermethrin results in increased expression of ATP6V1F mRNA | CTD | PMID:22528246 | Atp6v1f | Rat | D-gluconic acid | multiple interactions | EXP | | 6480464 | [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of ATP6V1F mRNA | CTD | PMID:16556975 | Atp6v1f | Rat | deoxycholic acid | multiple interactions | EXP | | 6480464 | [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of ATP6V1F mRNA | CTD | PMID:16556975 | Atp6v1f | Rat | dextran sulfate | increases expression | ISO | Atp6v1f (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of ATP6V1F mRNA | CTD | PMID:35093514 | Atp6v1f | Rat | dextran sulfate | multiple interactions | ISO | Atp6v1f (Mus musculus) | 6480464 | evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ATP6V1F protein] | CTD | PMID:35362542 | Atp6v1f | Rat | dextran sulfate | decreases expression | ISO | Atp6v1f (Mus musculus) | 6480464 | Dextran Sulfate results in decreased expression of ATP6V1F protein | CTD | PMID:35362542 | Atp6v1f | Rat | dibutyl phthalate | decreases expression | ISO | Atp6v1f (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of ATP6V1F mRNA | CTD | PMID:17361019 | Atp6v1f | Rat | diethylstilbestrol | decreases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | Diethylstilbestrol results in decreased expression of ATP6V1F mRNA | CTD | PMID:36621641 | Atp6v1f | Rat | doxorubicin | increases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of ATP6V1F mRNA | CTD | PMID:29803840 | Atp6v1f | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of ATP6V1F mRNA | CTD | PMID:29391264 | Atp6v1f | Rat | ethanol | affects expression | ISO | Atp6v1f (Mus musculus) | 6480464 | Ethanol affects the expression of ATP6V1F mRNA | CTD | PMID:30319688 | Atp6v1f | Rat | Evodiamine | multiple interactions | ISO | Atp6v1f (Mus musculus) | 6480464 | evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ATP6V1F protein] | CTD | PMID:35362542 | Atp6v1f | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of ATP6V1F mRNA | CTD | PMID:24136188 | Atp6v1f | Rat | fulvestrant | multiple interactions | ISO | ATP6V1F (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATP6V1F gene | CTD | PMID:31601247 | Atp6v1f | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ATP6V1F mRNA | CTD | PMID:33387578 | Atp6v1f | Rat | hydroxyurea | increases mutagenesis | ISO | Atp6v1f (Mus musculus) | 6480464 | Hydroxyurea results in increased mutagenesis of ATP6V1F gene | CTD | PMID:16868089 | Atp6v1f | Rat | isoniazide | increases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | Isoniazid results in increased expression of ATP6V1F protein | CTD | PMID:40015660 | Atp6v1f | Rat | ivermectin | decreases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ATP6V1F protein | CTD | PMID:32959892 | Atp6v1f | Rat | L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of ATP6V1F mRNA | CTD | PMID:19483382 | Atp6v1f | Rat | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of ATP6V1F mRNA | CTD | PMID:24136188 | Atp6v1f | Rat | N-methyl-N-nitrosourea | increases mutagenesis | ISO | Atp6v1f (Mus musculus) | 6480464 | Methylnitrosourea results in increased mutagenesis of ATP6V1F gene | CTD | PMID:16868089 | Atp6v1f | Rat | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of ATP6V1F mRNA | CTD | PMID:24136188 | Atp6v1f | Rat | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of ATP6V1F mRNA | CTD | PMID:24136188 | Atp6v1f | Rat | nitrates | multiple interactions | ISO | Atp6v1f (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ATP6V1F more ... | CTD | PMID:35964746 | Atp6v1f | Rat | O-acetyl-L-carnitine | increases expression | EXP | | 6480464 | Acetylcarnitine results in increased expression of ATP6V1F mRNA | CTD | PMID:14654561 | Atp6v1f | Rat | omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of ATP6V1F mRNA | CTD | PMID:19483382 | Atp6v1f | Rat | osimertinib | increases expression | EXP | | 6480464 | osimertinib results in increased expression of ATP6V1F mRNA | CTD | PMID:38734218 | Atp6v1f | Rat | paracetamol | affects expression | ISO | Atp6v1f (Mus musculus) | 6480464 | Acetaminophen affects the expression of ATP6V1F mRNA | CTD | PMID:17562736 | Atp6v1f | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ATP6V1F mRNA | CTD | PMID:33387578 | Atp6v1f | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Atp6v1f (Mus musculus) | 6480464 | PPARA protein inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of ATP6V1F mRNA] | CTD | PMID:20936131 | Atp6v1f | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | Atp6v1f (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ATP6V1F mRNA | CTD | PMID:20936131 | Atp6v1f | Rat | pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of ATP6V1F mRNA | CTD | PMID:19483382 | Atp6v1f | Rat | rac-lactic acid | decreases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of ATP6V1F mRNA | CTD | PMID:30851411 | Atp6v1f | Rat | resveratrol | increases expression | ISO | Atp6v1f (Mus musculus) | 6480464 | resveratrol results in increased expression of ATP6V1F mRNA | CTD | PMID:22610192 | Atp6v1f | Rat | rotenone | increases expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | Rotenone results in increased expression of ATP6V1F mRNA | CTD | PMID:31648047 | Atp6v1f | Rat | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of ATP6V1F protein | CTD | PMID:38266420 | Atp6v1f | Rat | thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of ATP6V1F mRNA | CTD | PMID:19483382 | Atp6v1f | Rat | triphenyl phosphate | affects expression | ISO | ATP6V1F (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of ATP6V1F mRNA | CTD | PMID:37042841 | Atp6v1f | Rat | valproic acid | affects expression | ISO | Atp6v1f (Mus musculus) | 6480464 | Valproic Acid affects the expression of ATP6V1F mRNA | CTD | PMID:17292431 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















